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ABSTRACT 
Nanoemulsions are defined as isotropic, thermodynamically stable, transparent or translucent; dispersions of oil and water stabilized by 
surfactant molecules (forms an interfacial film) having the droplet size of 20-500nm. Ease of preparation and scale-up, stability and 
increased bioavailability are features of these formulations which have attracted the attention of researchers. Its basic principle lies in its 
ability to spontaneously generate fine o/w microemulsion under mild agitation following dilution with aqueous phases. These conditions 
mimic the digestive motility in the GIT necessary to provide the agitation required for In vivo self emulsification. Unlike emulsions, self-
nanoemulsified drug delivery systems (SNEDDS) generates microemulsion with a narrow droplet size distribution of less than 50 nm due to 
which these systems have also been addressed as nanoemulsions. Nanoemulsions (NE) are lipidic nanoformulations with droplet diameter in 
nanometer range have established tremendous attention as drug delivery formulations for lipophilic drugs due to their capability to increase 
solubility, permeation across biological membranes as well as their therapeutic efficiency of lipid soluble drugs due to predictable size-
distribution, high drug loading and stability under biological environment. However there is still relatively narrow insight regarding 
preparation, characterization and applications of nanoemulsions. This limitation unfolds the premise for current review article. In this 
review, we attempt to explore varying intricacies, methods of preparation, characteristics, and drug delivery applications of nanoemulsions 
to spike interest of those contemplating a foray in this field. 
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INTRODUCTION 
A perfect formulation system achieves the goals of 
enhanced therapeutic response with least toxicity. By way 
of the progress and advancement in time, knowledge and 
tools, drug formulations have been enlarge from simple 
blend and tablets, to extremely complicated structure, 
which are famous as novel drug formulation systems. 
Drawbacks in intravenous administration such as 
extravasations of drug or blood, thrombosis and catheter 
infections can be prevented by administering the drug 
orally and thus making the oral drug delivery system the 
most accepted way of administration 1. Though, oral drug 
deliverance is restricted by issues related to physico-
chemical properties of the drug i.e. poor solubility, low 
intestinal permeability, instability in the harsh acidic 
environment followed by rapid metabolism, all of which 
decreases oral bioavailability 2.With the advancement in 
the drug design, various molecules have been created to 
facilitate a potential medicinal effect. But the majority of 
the recently discovered molecules or chemical molecules is 
of high molecular weight (Phytochemicals) and belongs to 
biopharmaceutical classification system (BCS) –IV, with low 
water solubility and low intestinal permeation property. 
Hence these properties limit the bioavailability of orally 
administered drugs 3. This poor aqueous solubility not 
simply gives the low oral bioavailability of drug but also 
leads to elevate inter and intra matter inconsistency and 
lack in amount proportionality 4. Various techniques like 
micronization, complexation, solid dispersion and 
permeation improver with surfactant have been cited to 
overcome low solubility and intestinal permeation issues 5. 
In this era, Nanoformulations has brought a revolution in 
creating devices with novel concepts and in drug delivery 
systems. Recently, many “lipid based formulations (solid 
lipid nanoparticles, nanostructured lipid carriers”, 
nanoemulsion and liposomes) have been investigated to 
overcome the bioavailability issues associated with the oral 
administration of drugs 6. Avoidance of first pass 
metabolism of drug, improve mucosal adhesion, improved 
permeation across the intestinal membrane barrier, 
Majeed et al                                                                                                        Journal of Drug Delivery & Therapeutics. 2019; 9(2):520-527     
ISSN: 2250-1177                                                                                  [521]                                                                                 CODEN (USA): JDDTAO 
protection against harsh GI environment and controlled 
release are major mechanisms which further enhance the 
bioavailability, effectiveness of phyto-medicines as well as 
their tunable release profile in blood circulation. Besides 
that, lymphatic system “plays an essential role in 
absorption of long chain fatty acids, triglyceride, 
cholesterol, esters, lipid soluble vitamins and xenobiotic” 7, 
8. Nanoemulsions (NE) are lipidic nanoformulations with 
droplet diameter in nanometer range have established 
tremendous attention as drug delivery formulations for 
lipophilic drugs due to their capability to increase 
solubility, permeation across biological membranes as well 
as their therapeutic efficiency of lipid soluble drugs due to 
predictable size-distribution, high drug loading and 
stability under biological environment 9, 10. O/W 
Nanoemulsions possesses a core shell assembly wherein 
core shell acts as a pool for the assimilation of poorly water 
soluble drugs and hydrophilic shell provides a protective 
interface between the core and the external medium 11, 12.   
WHAT ARE NANOEMULSIONS 
Nanoemulsions are defined as isotropic, 
thermodynamically stable, transparent or translucent; 
dispersions of oil and water stabilized by surfactant 
molecules (forms an interfacial film) having the droplet size 
of 20-500nm 13. Ease of preparation and scale-up, stability 
and increased bioavailability are features of these 
formulations which have attracted the attention of 
researchers 14, 15. 
 
Figure 1: Structure of Nanoemulsion droplet 
Its basic principle lies in its ability to spontaneously 
generate fine o/w microemulsion under mild agitation 
following dilution with aqueous phases. These conditions 
mimic the digestive motility in the GIT necessary to provide 
the agitation required for In vivo self emulsification. Unlike 
emulsions, self-nanoemulsified drug delivery systems 
(SNEDDS) generates microemulsion with a narrow droplet 
size distribution of less than 50 nm due to which these 
systems have also been addressed as nanoemulsions. The 
fine droplets of this dosage form have the advantage of 
presenting the drug in a dissolved form with an increase 
interfacial area which helps in the better absorption of the 
drug which results in more uniform and reproducible 
bioavailability. Moreover, it has also observed that the drug 
is maintained in the dissolved state throughout the GIT 
which helps in enhancing the bioavailability of PWSD. In 
addition, the fine droplets offer large surface area for 
pancreatic lipase to hydrolyze the lipids and therefore 
enhance the rate of drug release. The adequate solubility of 
the drug in the lipid/surfactants blend, nature of the 
lipid/surfactant pair, the ratio between the lipid and the 
surfactant, the surfactant concentration and the uniform 
droplet size distribution following self-emulsification are 
necessary components to be monitored during the 
development of SMEDDS 13, 16, 17. 
ADVANTAGES OF NANOEMULSION 
 Nanoemulsion is one of the best approaches to increase 
water solubility of the lipophilic drugs, which in turns 
increases the bioavailability of the drug in the systemic 
circulation. As the droplets are in nano size it is having 
increased interfacial areas it effects the transport 
properties of the drug, which is an very important factor in 
drug delivery (sustained and targeted) 13, 14. 
 Plasma concentration profiles and bioavailability are more 
reproducible when the drugs are administered in 
nanoemulsion formulation 18, 14. 
 It has been observed that as the oil droplets are fine, it 
empty quickly from the stomach and increase proper 
distribution of the API throughout the intestinal tract. By 
doing so it minimizes irritation frequently observed with 
long contact of the drug and gut wall 13, 19. 
 Nanoemulsions based formulations are having higher 
capacity of solubilization than formulation based on simple 
micellar solutions. Nanoemulsions are also 
thermodynamically stable which offer advantage over 
emulsions and suspensions those are unstable dispersion 
system. Nanoemulsions can easily prepared by little energy 
input that is by less heat and mixing and it also has long 
shelf life 14. 
 They also provide ultra low interfacial tension and large 
o/w interfacial areas 14, 20, 21. 
 They also offer an advantage over existing self-emulsifying 
system in terms of rapid onset of action (no extra time for 
dispersion) and reduced inter subject variability in terms of 
GIT fluid volume. 
 Nanoemulsions may possess high kinetic stability and 
optical transparency resembling to microemulsions 18, 22. 
 The structures in the nanoemulsions are much smaller than 
the visible wavelength, so most nanoemulsions appear 
optically transparent, even at large loading 13, 18, 23. 
 Nanoemulsions are also used to deliver peptides that easily 
undergo enzymatic hydrolysis (degradation) in GIT 14, 24, 25. 
MAJOR COMPONENTS OF NANOEMULSION 
Oils: Selection of an appropriate oily phase is very 
important as it influences the selection of other ingredients 
of nanoemulsions, mainly in case of O/W nanoemulsions. 
Usually, the oil which has maximum solubilising potential 
for selected drug candidate is selected as an oily phase for 
the formulation of nanoemulsions. This helps to achieve 
maximum drug loading in the nanoemulsions 17, 21. 
Composition of naturally occurring oils and fats are 
mixtures of triglycerides. These triglycerides are consists of 
fatty acids (which have varying length of the chain and the 
extent of unsaturation). Triglycerides are classified as short 
(<5 carbons), medium (6-12 carbons), or long chain (>12 
carbons) and may be synthetically hydrogenated to 
decrease the degree of unsaturation, thereby conferring 
resistance to oxidative degradation. The choice of oily 
phase is often a compromise between its ability to 
solubilize the drugs and its ability to facilitate formation of 
nanoemulsion of desired characteristics. Thus mixture of 
oils can be used to meet both the requirements. For 
example, a mixture of fixed oil and medium chain 
triglycerides is used to have good balance between drug 
loading and emulsification 22. Triglyceride oils (both long 
and medium chain) with different degrees of saturation can 
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be used to formulate SMEDDS. Triglycerides are highly 
lipophilic and their solvent capacity for drugs is commonly 
a function of the effective concentration of ester groups, 
thus on weight basis medium chain triglycerides (MCT) 
have higher solvent capacity and resistance to oxidation 
compare to long chain triglycerides 17. Modified vegetable 
oils, oils and fats (digestible or non-digestible) such as palm 
oil, olive oil, corn oil, sesame oil, oleic acid, hydrogenated 
soybean oil, peanut oil, soybean oil and beeswax are also 
used as oil phase in nanoemulsion formulation 16. 
Surfactants: The surfactant should favour 
microemulsification of the oily phase and should also 
possess good solubilising potential for the hydrophobic 
drug compounds. The choice of the surfactant is critical for 
the nanoemulsion formulation. Surfactants with an HLB 
value <10 are hydrophobic (such as sorbitan monoesters) 
and form w/o nanoemulsion where as high HLB (>10) 
surfactants such as polysorbate 80 are hydrophilic and 
form o/w nanoemulsion. In many cases, mixture of 
lipophilic (low HLB) and hydrophilic surfactants (high 
HLB) may be required to obtain nanoemulsion 21. Below 
critical micellar concentration (CMC) of the surfactant in 
solution it increases drug solubility by giving regions for 
lipophilic drug interactions in solution. Above CMC, 
surfactants aggregate to form micelles with the lipophilic 
core and a lipophobic surface. The lipophilic core of the 
micelles influence the entrapment of drug (mostly 
lipophilic in nature), thus increasing its solubility. It has 
seen that when the content of the oil is more, surfactant 
concentrate on interface of the oil/water forming 
emulsions, where the lipophilic drug is solubilized inside 
the internal hydrophobic core. On the other hand when the 
oil content is low, minute oil-entrapped surfactant globules 
are produced, which are known as nanoemulsions 21. The 
surfactant used in nanoemulsion formation could be ionic 
or non-ionic but ionic surfactants are not preferred due to 
toxicological concerns. Non-ionic water soluble surfactants 
are commonly used for SMEDDS formulation. Among 
various surfactants that are available, lecithins, poloxamers 
and polysorbate 80 are most preferred. The usual 
surfactant concentration in SMEDDS formation and 
maintaining emulsion stage ranges from 30-60% w/w of 
the formulation. Concentration of the surfactant in the 
formulation should be determined properly as it is very 
while formulating nanoemulsion. It has been observed that 
high concentration of surfactants cause GI irritation. 
Relation between the size of the droplet and concentration 
of the surfactant should be realized properly. In some 
instances, when there is an increase of the surfactant 
concentration it lead to formulation of smaller droplets of 
the oil. This type of behavior has been observed in case of a 
mixture of saturated C8-C10 polyglycolized glycerides. This 
is due to the localization of the surfactants at the oil-water 
interface which stabiles the formulation. Sometimes it has 
also observed that the mean droplet size of the oil globules 
may increase with the increase of surfactant concentration 
21, 26. 
Co-surfactants: Most of the times, surfactant alone cannot 
lower theoil-water interfacial tension sufficiently to yield a 
nanoemulsion which necessitates the addition of an 
amphiphillic short chain molecule or cosurfactant to bring 
about the surface tension close to zero. Cosurfactants 
penetrate into the surfactant monolayer providing 
additional fluidity to interfacial film and thus disrupting the 
liquid crystalline phases which are formed when surfactant 
film is too rigid 21. Usually a very low HLB cosurfactant is 
used with a high HLB surfactant to modify the overall HLB 
of the system. Unlike surfactant, the cosurfactant may not 
be capable of forming self-associated structures like 
micelles on its own. Hydrophilic cosurfactants preferably 
alcohols of intermediate chain length such as hexanol, 
pentanol and octanol, which are known to reduce the 
oil/water interface and allow the spontaneous formation of 
nanoemulsion 16, 18. 
Co-solvents: Production of an optimum nanoemulsion 
requires a highconcentration of surfactants, that is 
generally more than 30% w/w. Various organic solvents 
like glycerol, polyethylene glycol(PEG), ethanol, propylene 
glycol (PG) are used for oral delivery of the drug, and this 
cosolvents are having efficacy to dissolve large amount of 
water soluble surfactant or the API in the lipid base. Mostly 
it makes the environment more lipophilic by decreasing the 
dielectric constant of aqueous phase 18. There are some 
cosolvents like alcohols and other volatile substances have 
disadvantage of evaporating into the soft gelatin or hard 
gelatin capsules shells of the in conventional SMEDDS 
which leading to precipitation of drug. Thus, formulation 
should be free from alcohol while designing 18, 21, 27. 
METHODS OF PREPARATION OF 
NANOEMULSIONS 
Nanoemulsions are made from various excipients like 
surfactants those are approved for internal human use and 
some food materials 'Generally Recognized as Safe' by the 
Food and Drug Administartion. Nanoemulsions can be 
easily produced in large quantities by mixing aqueous 
phase with a water-immiscible oil phase using a process 
called high-stress, mechanical extrusion, which is easily 
available. As nanoemulsions are having very small droplet 
size, it can be effectively prepared by high-pressure 
equipment. Mostly equipments used for the formulation of 
the nanoemulsion are: 
a. High-pressure homogenization and 
b. Microfluidization 
Both the equipments can be used for laboratory as well as 
industrial scale. 
Other methods are also used in the formulation of 
nanoemulsion like, Ultrasonification and spontaneous 
emulsification which are also suitable for laboratory scale 
and not used for the commercial production 14, 21, 28.
 
 
 
 
 
 
 
 
Majeed et al                                                                                                        Journal of Drug Delivery & Therapeutics. 2019; 9(2):520-527     
ISSN: 2250-1177                                                                                  [523]                                                                                 CODEN (USA): JDDTAO 
Table 1: Different techniques employed for preparation of Nanoemulsions 
Technique 
 
Formulation 
 
Conclusions 
 
Ref 
 
High pressure homogenization Oral lipid nanoemulsion 
(primaquine) 
Enhanced oral bioavailability, 10-200 nm 
particle size 
29 
Pseudoternary phase diagram + 
spontaneous emulsification method 
Ramipril nanoemulsion Increased bioavailability, droplet size 80.9 nm 30 
High pressure homogenization O/W nanoemulsions Improved skin hydration and elasticity 31 
Spontaneous emulsification O/W nanoemulsion 
(aceclofenac) 
Nanoemulsion with potential for transdermal 
delivery of aceclofenac 
32 
Spontaneous emulsification Celecoxib nanoemulsion Enhanced physical and chemical stability of 
celecoxib in nanoemulsion 
33 
High pressure homogenization Lecithin-based nanoemulsions 
(progesterone) 
Improved  permeation  rates  of  progesterone 
with long-term stability 
34 
High pressure homogenization Prednicarbate nanoemulsion Increased chemical stability of the drug in 
formulation 
35 
Phase inversion temperature method Acyclovir-loaded multiple 
W/O/W nanoemulsions 
Excellent physicochemical stability for 6 mo at 
RT, mean droplet size of 100 nm 
36 
Spontaneous nanoemulsification 
method 
Clotrimazole nanoemulsion Improved solubility of clotrimazole, mean 
globule size <25 nm 
37 
Ultrasonic emulsification method Basil oil nanoemulsion Nanoemulsions with droplet size of 29.6 nm, for 
food preservation 
38 
High-pressure homogenizer Dimethyl silicone dry 
nanoemulsion inhalation 
Effective in acute lung injury, particle size of 
19.8 nm 
39 
Microfluidization method Pitavastatin-containing 
nanoemulsions 
Enhanced permeation 40 
High-pressure homogenization+ 
ultrasound 
Nanoemulsion Reduced energy demand for emulsification, low 
particle dimensions and higher stability 
41 
Sonication method Saponin-stabilized quercetin-
loaded o/w nanoemulsion 
Stable for 45 d at RT, mean particle size of 
52±10 nm 
42 
High-pressure homogenization Paclitaxel-baicalein 
nanoemulsion 
Strategy to overcome multidrug resistance 43 
Nanoemulsion templating PLGA nanoparticles Imaging agents for biomedical purposes 44 
Spontaneous emulsification method Chitosan films with 
cinnamaldehyde nanoemulsions 
Good UV barrier properties 45 
 
CHARACTERIZATION OF NANOEMULSIONS 
The prepared nanoemulsions are evaluated for following 
parameters: 
Dye Solubilization 46 
A water soluble dye is solubilized within the aqueous phase 
of the w/o globule but is dispersible in the o/w globule. An 
oil soluble dye is solubilized within the oil phase of the o/w 
globule but is dispersible in the w/o globule.  
Measurment of Droplet Size and Polydispersity Index  
The mean particle size and polydispersity index are 
measured at 250C by dynamic light scattering (DLS) using a 
Malvern Zetasizer. The size of the particles is measured by 
using disposable capillary cuvette equipped with 
electrodes. To avoid multiple scattering effects in the 
measurements, samples are diluted 100-fold with double-
distilled water immediately before measurement 47. The 
droplet size and poly dispersity index of the investigated 
samples is obtained (in triplicate) by calculating the 
average of 13 measurements at an angle of 1730 48, 49. 
Interfacial Tension 50: By measuring the interfacial 
tension the properties of nanoemulsion can be studied and 
Spinning-drop apparatus can be used to measure the ultra 
low interfacial tension. Interfacial tensions are derived 
from the measurement of the shape of a drop of the low-
density phase, rotating it in cylindrical capillary filled with 
high-density phase. 
Particle Size Analysis: For the measurement of particle 
size and their distribution dynamic light scattering (DLS) 
method is generally used in case of nanoemulsion 51.  
Conductance Measurement 46 
Conductance measurements are usually carried out to 
determine the nature of the continuous phase and to detect 
phase inversion phenomena; the electrical conductivity 
measurements are highly useful. In o/w nanoemulsion 
where the external phase is water, are highly conducting 
whereas w/o are not, since water is the internal or 
dispersed phase. Dielectric measurements are a powerful 
means of probing both structural and dynamic features of 
nanoemulsion systems. 
Refractive Index: Refractive index of nanoemulsion is 
determined by using an Abbes type refractometer. The 
refractive index of each sample measured three times, and 
mean value and standard deviation (SD) are calculated 52. 
Viscosity 53 
The viscosity of the nanoemulsions is measured by 
Brookfield viscometer and the spindle size of 62 and rpm 
60 is used for the study and the viscosity is expressed in 
terms of centipoises. 
Percent Drug Loading: To determine percent drug 
loading, pre-weighed nanoemulsion is extracted by 
dissolving in 25ml suitable solvent, then the extract is 
analyzed spectrophotometrically/ by using HPLC against 
the standard solution of drug. Drug content is determined 
by reverse phase HPLC method using different columns of 
appropriate porosity 54.  
Determination of Entrapment Efficiency 55: Entrapment 
efficiency (EE %) is determined by measuring the 
concentration of free drug (un-entrapped) in aqueous 
medium. This is the prime importance, as it influences the 
release characteristics of drug molecule. The amount of 
Majeed et al                                                                                                        Journal of Drug Delivery & Therapeutics. 2019; 9(2):520-527     
ISSN: 2250-1177                                                                                  [524]                                                                                 CODEN (USA): JDDTAO 
drug encapsulated per unit weight of nanoformulation is 
determined after separation of the entrapped drug from the 
nanoemulsion formulation. The entrapment efficiency is 
determined by following formula:  
     
                                                       
                               
        
In Vitro Permeation Studies 56: In vitro skin permeation 
studies are carried out on abdominal skins obtained from 
male rats weighing 250±10 g by using Keshary Chien-
diffusion cell. The skin is placed between the donor and the 
receptor chamber of vertical diffusion cell. The receptor 
chamber is filled with fresh water containing 20% ethanol. 
The temperature of the receiver chamber is set at 37oC and 
the solution in the receptor chamber is stirred continuously 
at 300 rpm. The formulations are placed in the donor 
chamber and the solution in the receiver chamber is 
removed at different time intervals for GC analysis and 
replaced immediately with an equal volume of fresh 
solution. Each sample is performed three times .The 
cumulative corrections are made to obtain the total 
amounts of drugs permeated at each time interval. The 
cumulative amounts of drug permeated through rat skins 
are plotted as a function of time. The permeation rates of 
drug at a steady-state through rat skins are calculated from 
the slope of linear portion of the cumulative amount of drug 
permeated through the rat skins per unit area versus time 
plot. 
Stability studies 53 
For the evaluation of nanoemulsions, the stability study is 
an important criterion to be considered. Nanoemulsions 
are characterized by its high stability than the other 
dispersed systems. The various stability studies conducted 
for nanoemulsions include:  
a) Thermodynamic stability studies, and  
b) Accelerated stability studies. 
a. Thermodynamic stability studies 
In Thermodynamic stability studies the selected 
formulations are subjected to different thermodynamic 
stability studies tests to assess their physical stability 57. 
The process involved 3 cycles, initially heating and cooling 
cycles are carried out 6 times, followed by alternately 
heating and cooling at 40°C and 4°C respectively, this is 
followed by centrifugation at 3500 rpm for 30 min. Each 
cycle is observed for changes in the formulation due to 
phase separation. 
b. Accelerated stability studies 
Accelerated stability studies are performed on optimized 
formulation. Three batches of the nanoemulsions are taken 
in glass vials and were kept at a temperature of 30°C, 40°C, 
and 60°C at ambient humidity condition 58. The samples are 
withdrawn for studying drug content as per standard 
procedure mentioned in International Conference on 
Harmonisation (ICH) Q1 guidelines. The amount of the drug 
degraded at each time interval is calculated nand order of 
the reaction is determined by graphical method. The 
degradation rate constant (K) is determined for each 
temperature. 
APPLICATIONS OF NANOEMULSIONS IN VARIOUS 
FIELDS 
1. Nanoemulsions in drug delivery 
Nanoemulsions have been used in most topical, ocular, 
intravenous, internasal and oral drug delivery. These 
applications influence the lyphophilic nature of 
nanoemulsions to solvate water-insoluble drugs; and 
tunable charge and rheology of nanoemulsions to formulate 
aqueous solutions that can be easily delivered to patient. 
Though skin protects us from the external environment, it 
also acts as a transport barrier against administration of 
drugs through the skin. Topical medication formulated 
using nanoemulsions can provide unique advantages as the 
dispersed phase of O/W nanoemulsions enables enhanced 
solubility of lipophilic drugs in the oil phase and the 
continuous phase provides a mild, skin-friendly 
environment that can dissolve biopolymers such as alginate 
for adjusting the formulation rheology, appearance and 
texture. A considerable number of studies focused on using 
nanoemulsions for topical drug delivery. Few of the above-
mentioned studies included permeation tests to evaluate 
the effectiveness of topical delivery. Some studies claim 
that owing to the relatively small size and low z-potential of 
nanoemulsion formulations, hydrophobic drugs are 
delivered more efficiently than are suspensions of these 
drugs 59.  
Mou et al. prepared hydrogel thickened nanoemulsions that 
had higher permeation rates as compared to conventional 
hydrogels 60. Researchers have also explored the use of 
nanoemulsions in other modes of drug delivery such as 
ocular, intravenous, intranasal and oral delivery. 
Nanoemulsions have also been used as ultrasound imaging 
agents 61. Kaneda et al. prepared nanoemulsions containing 
perfluorocarbons for quantitative molecular imaging and 
targeted therapeutics 62. Gianella et al., 63 engineered a 
multifunctional nanoemulsion based platform to enable an 
imaging-guided therapy. Researchers evaluated the utility 
of the platform in a colon cancer mouse model. In this 
study, oil-in-water nanoemulsions carried iron oxide 
nanocrystals for MRI, the fluorescent dye Cy7 for NIRF 
imaging, and the hydrophobic glucocorticoid prednisolone 
acetate valerate for therapeutic purposes. 
II.  Nanoemulsions in Biotechnology 64 
Many enzymatic and biocatalytic reactions are conducted in 
pure organic or aqua-organic media. Biphasic media are 
also used for these types of reactions. The use of pure a 
polar media causes the denaturation of biocatalysts and the 
use of water-proof media is relatively advantageous. 
Enzymes in low water content display and have; 
 Enhanced solubility in non-polar reactants.  
 Possibility of shifting thermodynamic equilibria in 
favour of condensations.  
 Improvement of thermal stability of the enzymes, thus 
enabling reactions to be carried out at higher 
temperatures.  
Many enzymes including lipases, esterases, 
dehydrogenases and oxidases often function in the cells in 
microenvironments that are hydrophobic in nature. In 
biological systems many enzymes operate at the interface 
between hydrophobic and hydrophilic domains and these 
usually interfaces are stabilized by polar lipids and other 
natural amphiles. Enzymatic catalysis in nanoemulsions has 
been used for a variety of rxns, such as peptides and sugar 
acetals transesterification, synthesis of esters and steroid 
transformation. Lipases are the most commonly used class 
of enzymes 65. 
III. Nanoemulsions in Cosmeticology 
Nanoemulsion is used as vehicle for controlled delivery and 
as effective transport vehicle. The Kemira Nanogel 
nanoemulsion based carrier system is a patented system 
for cosmetic purpose which enhances skin production and 
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penetration of API. Apart from that it also provide good 
skin feel 66. Topical administration itself has many 
advantages and by combining it with nanoemulsion, this 
formulatory may impart the better way of drug delivery 
system. It can bypass the hepatic first pass metabolism of 
the drug and related toxicity effects 67.  
IV. Nanoemulsions in Food industry 
Nanoemulsions offer a wide range of applications due to 
their compositional flexibility in various fields including 
food and beverage industries. As compared to 
microemulsions, nanoemulsions have found a lot of 
applications in food processing due to its very small size, 
thermodynamic stability, continuous self-assembly with 
hydrophilic and hydrophobic portion, transparency and 
weak light wave scattering capacity, which eventually lead 
to their incorporation into optically transparent products 
such as fortified soft drinks and waters. Disparate micro or 
other conventional emulsions, nanoemulsions can be 
prepared to be more viscous or gel-like with very low 
droplet concentrations, which can be easily used to make 
products with low fats and novel texture 68. Nanoemulsions 
can enhance the shelf-life of industrial products due to the 
stability of the droplet of the nanoemulsion, stability to 
particle aggregation and gravitational separation. Joe et al. 
used nanoemulsions prepared from sunflower oil for the 
processing of Indo-Pacific king mackerel steaks and 
observed no microbial growth up to 12 h and the shelf life 
of the product was increased up to 48 h 69. 
CONCLUSION 
This review focuses on nanoemulsions as drug delivery 
vehicle. Nanoemulsion formulations show numerous 
advantages for the delivery of drugs, biological or 
diagnostic agents and are able to protect labile drug, 
increase drug solubility, enhance bioavailability, control 
drug release and reduce patient variability.  Moreover, 
nanoemulsions have been used traditionally in clinics for 
more than four decades as total parenteral nutrition fluids.  
In recent years nanoemulsions with droplet size of less 
than 100 nm have drawn great attention because of their 
potential applications in pharmaceutical, cosmetics, 
biotechnology and food industries as a better delivery 
system due to their small droplet size, transparency, and 
high kinetic stability.  But still there is need to emphasize 
on toxicological evaluation of the prepared nanoemulsions, 
which can be a wide area of research in future. 
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